Search
Compass Therapeutics Inc.
CMPXAdd to Watchlist
2.360USD
-0.120-4.84%
Close 08-20 16:00（ET）
425.91MMarket Cap
LossP/E TTM
Compass Therapeutics Inc.'s Company Valuation
Currency: USD Updated: 2026-08-20The current valuation score of Compass Therapeutics Inc. is 6.90, ranking 265 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.91, which is -62.11% below the recent high of -2.24 and -162.22% above the recent low of -15.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.